Skip to content
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
SV
January 29, Lund Aktiedagen
December 11, 2018
Share
News
February 14, 2025
Year-end report January-December 2024 CombiGene AB (Publ)
January 28, 2025
Discontinuation of research activities
January 9, 2025
Stockslätten AB acquires all shares from Strategic Partners A/S
January 9, 2025
Clarification regarding the management’s role during the restructuring period
January 9, 2025
CombiGene initiates restructuring as part of strategic review to maximize shareholder value
December 17, 2024
CombiGene AB (publ): Nominating committee
December 10, 2024
Bulletin from the Extraordinary General Meeting of CombiGene AB (publ)
December 2, 2024
CombiGene conducts Extraordinary General Meeting
Load more
